GlassScriptPhysician profile
Lance R Pickard
NPI 1841511912
$3,827.02
in general payments reported to CMS, 2019-2025
43 companies · $798 in 2025
The $798 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $354 · 2021: $320 · 2022: $624 · 2023: $464 · 2024: $788 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,051.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $362.42 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $327.37 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $312.86 | 2020-2025 | |
| Antares Pharma, INC. | $308.10 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Astrazeneca Pharmaceuticals LP | $281.61 | 2020-2025 | Breztri, Farxiga, Airsupra |
| Dendreon Pharmaceuticals LLC | $265.23 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $264.63 | 2019-2025 | Veozah |
| Ferring Pharmaceuticals INC. | $156.84 | 2019-2025 | Adstiladrin |
| Storz Medical America, INC. | $137.53 | 2025 | |
| Axonics, INC. | $122.35 | 2020-2022 | |
| Abbvie INC. | $112.54 | 2021-2023 | |
| Blue Earth Diagnostics | $112.42 | 2019-2023 | |
| Glaxosmithkline, LLC. | $103.35 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Boston Scientific Corporation | $97.58 | 2019-2024 | Lithovue |
| Pfizer INC. | $72.95 | 2023-2024 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Pickard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.